Predicting MRI-diagnosed microvascular obstruction and its long-term impact after acute myocardial infarction.

Authors

Johannes Brado, Ramona Schmitt, Manuel Hein, Christian Valina, Collin Steinhauer, Martin Soschynski, Christopher Schuppert, Christopher L Schlett, Franz-Josef Neumann, Dirk Westermann, Philipp Ruile, Philipp Breitbart

Published in

Clinical research in cardiology : official journal of the German Cardiac Society. Jul 07, 2025. Epub Jul 07, 2025.

Abstract

Microvascular obstruction (MVO) at cardiac magnetic resonance imaging (CMR) is a well-described risk factor for cardiac events after acute myocardial infarction (MI).
Predicting MVO using cardiac biomarkers and performing risk stratification according to extent of MVO.
We conducted a retrospective study including all patients with an acute MI and a subsequent CMR during the same hospital stay between October 2008 and August 2023. Patients were grouped according to the presence of any MVO and of relevant MVO (defined as > 1.55% of LV myocardial mass). The prediction of MVO based on peak high sensitivity cardiac troponin T (hs-cTnT) levels was analyzed. Survival according to MVO status was assessed in the entire study population.
We evaluated 597 patients with CMR 3 days [interquartile range 2-4 days] after myocardial infarction. MVO was present in 163 patients (27.3%) and relevant MVO in 100 patients (16.8%). Patients with MVO had significantly higher peak hs-cTnT levels compared to those without (p < 0.001). An hs-cTnT cut-off value of > 2455.0 ng/L predicted present MVO (area under the curve (AUC) 0.824), while a cut-off value of 3975.0 ng/L predicted relevant MVO (AUC 0.837). Relevant MVO was a predictor of all-cause mortality in the entire study population (hazard ratio (HR) 3.89 (1.50-10.09)), with an even stronger association in patients with an LVEF > 35% (HR 5.91 (1.79-19.56)).
Higher peak hs-cTnT levels are strong predictors of MVO. Described cut-off values could serve as a screening tool. Relevant MVO is a significant predictor of all-cause mortality following acute MI, especially in patients with LVEF > 35%.

PMID:
40622620
Bibliographic data and abstract were imported from PubMed on 07 Jul 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.